We are especially interested in isolating dendritic cells because these cells may be stimulated with tumor-associated antigens to initiate CD8+ T lymphocytes (CD8-T) assault on tumors, as an immunotherapy called dendritic cell vaccination (DCV) [11,12]. Here, CD8A is linked to neoplasm.